EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2020
Media advisory: The article is linked to this news release
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.1288?guestAccessKey=cfd3ac72-e954-47d8-b81b-c40f03672f57&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033120
What The Viewpoint Says: This article describes treatment initiatives being undertaken for novel coronavirus 2019 at an ophthalmology center in Singapore.
Authors: Ivan Seah Yu Jun, M.B.B.S., of National University Hospital of Singapore, is the corresponding author.
Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.